Daraxonrasib combined with chemotherapy shrinks metastatic pancreatic tumors in early-stage trialNovember 22, 2026
New Cedars-Sinai center aims to advance the treatment of gastrointestinal and liver diseasesNovember 22, 2026
General Daraxonrasib combined with chemotherapy shrinks metastatic pancreatic tumors in early-stage trialBy Healthcare Propulsion StaffNovember 22, 20260 Daraxonrasib combined with chemotherapy caused substantial tumor shrinkage in patients with pancreatic cancer that had spread to other parts of…